SCHEMBL6014075

SCHEMBL6014075

CCCCCCCCCCCC(CCCCCC)CCCCCCCC/C=C\CCCCCCCC(=O)O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.79
PPARD Q03181 5/20 0.79
PPARA Q07869 5/20 0.79
F7 P08709 5/20 0.79
F3 P13726 5/20 0.79
TERT O14746 3/20 0.79
PTPN1 P18031 3/20 0.79
HSD17B10 Q99714 3/20 0.79
FABP4 P15090 3/20 0.79
TOP1 P11387 3/20 0.79
MAPT P10636 2/20 0.79
BLM P54132 2/20 0.79
LMNA P02545 2/20 0.79
ALOX15 P16050 2/20 0.79
DUSP3 P51452 2/20 0.79
CYP19A1 P11511 2/20 0.79
PTGS1 P23219 2/20 0.79
NR4A2 P43354 2/20 0.79
SIRT6 Q8N6T7 2/20 0.79
PTPN7 P35236 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9793321 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
SCHEMBL10599586 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
SCHEMBL27436687 0.97 PPARG (0.74) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL18836839 0.97 PPARG (0.74) PPARGPPARDPPARAF7F3
SCHEMBL687442 0.95 PPARG (0.81) PPARGPPARDPPARAF7F3
SCHEMBL16830709 0.95 PPARG (0.71) PPARGPPARDPPARAF7F3
SCHEMBL27655743 0.95 PPARG (0.71) PPARGPPARDPPARAF7F3
SCHEMBL29002730 0.93 PPARG (0.69) PPARGPPARDPPARAF7F3
SCHEMBL27652428 0.93 PPARG (0.68) PPARGPPARDPPARAF7F3
SCHEMBL3744159 0.92 PPARG (0.77) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060134239-A1 Agents against microorganisms containing patchouli oil, patchouli alcohol and/or the derivatives thereof HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2006-06-22 US disclosed
US-6750193-B1 TABLETTING A PARTICULATE PREMIX TO FORM TABLETS WITH A CAVITY; FILLING THE CAVITY TABLETS WITH THE MELT SUSPENSION OR EMULSION OF A MATRIX MATERIAL AT LEAST ONE ACTIVE MATERIAL DISPERSED OR SUSPENDED IN THE MATRIX MATERIAL HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-06-15 US disclosed
US-6562769-B1 Perfume beads, which may be incorporated in detergents and laundry treatment and aftertreatment compositions HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060134239-A1 Agents against microorganisms containing patchouli oil, patchouli alcohol and/or the derivatives thereof POLR1C, DPM1, PCNA PPARG 1709/4885PPARD 847/4885PPARA 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.